Exxonmobil Investment Management Inc. TX lowered its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 12.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 63,760 shares of the medical research company’s stock after selling 9,324 shares during the period. Exxonmobil Investment Management Inc. TX’s holdings in Thermo Fisher Scientific were worth $12,107,000 as of its most recent filing with the SEC.
Other institutional investors have also bought and sold shares of the company. Bank of Nova Scotia Trust Co. acquired a new position in shares of Thermo Fisher Scientific during the 3rd quarter worth $106,000. Chicago Partners Investment Group LLC acquired a new position in shares of Thermo Fisher Scientific during the 2nd quarter worth $108,000. Shine Investment Advisory Services Inc. acquired a new position in shares of Thermo Fisher Scientific during the 2nd quarter worth $113,000. Ropes Wealth Advisors LLC raised its holdings in shares of Thermo Fisher Scientific by 15.8% during the 2nd quarter. Ropes Wealth Advisors LLC now owns 710 shares of the medical research company’s stock worth $124,000 after buying an additional 97 shares in the last quarter. Finally, Atlantic Trust LLC acquired a new position in shares of Thermo Fisher Scientific during the 2nd quarter worth $138,000. 86.39% of the stock is owned by institutional investors.
In other news, CEO Marc N. Casper sold 50,000 shares of the stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $191.74, for a total value of $9,587,000.00. Following the completion of the sale, the chief executive officer now owns 302,577 shares of the company’s stock, valued at $58,016,113.98. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 0.49% of the company’s stock.
Shares of Thermo Fisher Scientific Inc. (TMO) traded up $9.49 during mid-day trading on Wednesday, hitting $224.11. The stock had a trading volume of 3,372,789 shares, compared to its average volume of 1,440,000. The firm has a market capitalization of $89,400.00, a PE ratio of 38.05, a price-to-earnings-growth ratio of 1.77 and a beta of 1.06. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.85. Thermo Fisher Scientific Inc. has a 12 month low of $146.08 and a 12 month high of $226.00.
Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Wednesday, January 31st. The medical research company reported $2.79 earnings per share for the quarter, beating the consensus estimate of $2.66 by $0.13. The company had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $5.72 billion. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The business’s quarterly revenue was up 22.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.41 earnings per share. equities analysts forecast that Thermo Fisher Scientific Inc. will post 9.36 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Monday, April 16th. Stockholders of record on Thursday, March 15th will be paid a $0.17 dividend. This is a boost from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. This represents a $0.68 annualized dividend and a dividend yield of 0.30%. Thermo Fisher Scientific’s dividend payout ratio is presently 10.19%.
A number of equities analysts have recently commented on the company. Zacks Investment Research raised Thermo Fisher Scientific from a “sell” rating to a “hold” rating in a report on Saturday, January 20th. BTIG Research initiated coverage on Thermo Fisher Scientific in a report on Friday, January 5th. They issued a “buy” rating and a $230.00 target price for the company. Evercore ISI initiated coverage on Thermo Fisher Scientific in a report on Wednesday, January 3rd. They issued an “outperform” rating and a $220.00 target price for the company. Leerink Swann reaffirmed an “outperform” rating and issued a $200.00 target price (down previously from $216.00) on shares of Thermo Fisher Scientific in a report on Monday, December 4th. Finally, Deutsche Bank set a $226.00 target price on Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Thursday, October 26th. Two research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $212.21.
WARNING: “Exxonmobil Investment Management Inc. TX Sells 9,324 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this report can be read at https://www.dispatchtribunal.com/2018/02/01/thermo-fisher-scientific-inc-tmo-shares-sold-by-exxonmobil-investment-management-inc-tx.html.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.